Both in Pharmaceuticals
Minerva Neurosciences vs PepGen
Over the past year NERV returned +59.5% and PEPG returned −49.6%; their daily moves had a correlation of 0.11.
NERV +59.5% PEPG −49.6%Growth of $1, one year, split-adjusted
| Metric | NERV | PEPG |
|---|---|---|
| Price | $3.35 | $2.34 |
| Market cap | $160.0M | $162.1M |
| Today | −1.47% | −9.65% |
| 1 month | −30.8% | −24.0% |
| 6 months | −43.9% | −44.7% |
| Year to date | −16.7% | −64.1% |
| 1 year | +58.0% | −53.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $75.3M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 90.4% |
| Short % of float | 6.0% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).